About Us
BETTER pharmacology through thoughtful design
A robust pipeline of innovative, safe precision medications.
About CADRx
TEAM
APPROACH
PROBLEM
CADRx Precision Medicines has built a team of clinicians, scientists, and advisors with deep expertise in 3D pharmaceutical printing, cancer prevention, drug development, and the oral cancer patient experience.
PROBLEM
APPROACH
PROBLEM
Oral leukoplakia lesions lack appealing treatment options.
Current standard of care: watchful waiting until lesions need to be surgically excised, or chemotherapy or radiation Tx are indicated (severe morbidity). To reduce oral cancer incidence, the safest and most effective way is to remove oral premalignant lesions, which lack appea
Oral leukoplakia lesions lack appealing treatment options.
Current standard of care: watchful waiting until lesions need to be surgically excised, or chemotherapy or radiation Tx are indicated (severe morbidity). To reduce oral cancer incidence, the safest and most effective way is to remove oral premalignant lesions, which lack appealing treatment options.
Cancer prevention requires especially well tolerated drug products with a high margin of safety.
APPROACH
APPROACH
APPROACH
3D printed dosage forms of LeukoPlax enable directional, local delivery of very low doses of synergistic drugs that are in clinical use for other indications, with over 1000 fold improvement in pharmacokinetic profiles (as measured by total dose of drug).
Early treatment of clinically visible leukoplakia can avoid future development into oral cancers with high mortality & severe morbidity.
